MTSEA prevents ligand binding to the human melanocortin-4 receptor by modification of cysteine 130 in transmembrane helix 3

FEBS Lett. 2005 Jan 3;579(1):285-91. doi: 10.1016/j.febslet.2004.11.087.

Abstract

We have investigated the effect of the sulfhydryl-reactive reagent, methyl thiosulfonate ethylammonium (MTSEA), on ligand binding to the human melanocortin-4 (MC4) receptor stably expressed in HEK-293 cells. MTSEA inhibited binding of the agonist, 125I-NDPalpha-MSH, and the antagonist, 125I-SHU9119, in a concentration-dependent manner. Pre-incubation of cells with either the agonist or antagonist protected from subsequent MTSEA inhibition of radioligand binding. Mutation of Cys130 in transmembrane helix 3 to alanine, whilst not affecting ligand binding, led to a complete loss of the inhibitory effect of MTSEA. Since other types of sulfhydryl-reactive reagents had no effect on ligand binding, we conclude that covalent modification of Cys130 by MTSEA disrupts ligand binding by neutralising a close-by negative charge, most likely on Asp126.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Motifs / genetics
  • Amino Acid Sequence
  • Binding Sites / genetics
  • Cysteine / chemistry
  • Cysteine / drug effects*
  • Cysteine / genetics
  • Ethyl Methanesulfonate / analogs & derivatives*
  • Ethyl Methanesulfonate / pharmacology*
  • Humans
  • Ligands
  • Models, Molecular
  • Molecular Sequence Data
  • Mutation / genetics
  • Protein Structure, Secondary / genetics
  • Receptor, Melanocortin, Type 4 / chemistry*
  • Receptor, Melanocortin, Type 4 / drug effects*
  • Receptor, Melanocortin, Type 4 / metabolism

Substances

  • Ligands
  • Receptor, Melanocortin, Type 4
  • methanethiosulfonate ethylammonium
  • Ethyl Methanesulfonate
  • Cysteine